Finch Therapeutics Group, Inc. (FNCH)
Finch Therapeutics Group, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Boston, MA, US. The stock last traded at $10.20, up 0.99% on the session, giving a market capitalisation of $16.4M. On trailing twelve-month figures it carries a trailing P/E of -1.18, a net margin of 0.0%. Its beta of 1.48 implies it has historically moved more than the broad market.
Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.
Finch Therapeutics Group, Inc. is most often compared with the following Healthcare names: